quality improvement studies where high benchmarks of >95% are now recommended. There is inadequate justification for this. -There are significant breaks between the post intervention periods. Was the unit aware that these were evaluation periods?
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GENERAL COMMENTS
This manuscript addresses the important issue of potential misuse of antimicrobial agents in critical care medicine. The authors report the results of a prospective cohort study that demonstrated significant improvements in antibiotic prescribing after the implementation of a computerized decision support system (CDSS) in a single hospital. A net increase of 10% in guideline adherence was observed during the five year observation period. This sustained long-term effect of CDSS makes the paper especially important, as a body of literature suggests that computerized prescribing can lead to more costeffective care. The manuscript is concise and well-written and should be of interest to readers of the Journal, however, it requires a revision to address several important gaps. 1. Two main endpoints for assessing the impact of CDSS in the study were percentage of days when the prescribing was concordant with ICU guidelines, and percentage of antibiotic-free days. A reader excited by this report would surely be interested in more hard data on the antibiotic usage (e.g., DDD/1,000 patient days or number of prescribing decisions or the average duration of treatment). Unfortunately, the authors have not provided any primary data for the comparison of "before/after" cohorts. 2. The authors have analyzed the rates of fungal infections (Tables 1  and 3) , however, it remains unclear whether their assessment of antimicrobial treatment is limited to antibiotic therapy (in accordance with study endpoints) or indeed includes antifungal and antiviral agents as the title of the paper implies. 3. It is a pity that such a successful CDSS intervention has not been adequately described. One would like, at least, to see an example of algorithms or pathways for managing infections in the CDSS, and to know how it works (e.g., are the CDSS rules deterministic or probabilistic? Is the system stand-alone or a component of a larger clinical information system and integrated into a laboratory information system? Is the use of this CDSS passive (advisory role only) or active/prescriptive when direct action is required (e.g., a clinician could not easily order a drug which is not indicated to a condition according to the guideline). 4. While the findings of this cohort study are plausible and there was no significant difference in the patient mix, it would be important to clarify how much rotation has occurred among clinical staff or users of the system and whether there were any outbreaks of infection due to multi-drug resistant organisms occurring in the pre-intervention or intervention periods. These issues are of relevance since there were significantly larger proportions of wound and soft tissue infections in the pre-intervention period (Table 1) . 5. The meaning of criteria used to calculate the primary endpoint needs to be clarified, as expressions such as "missing attention to prior antibiotic regime", "insufficient diagnostic proceedings", "the neglect of de-escalation strategies" etc (page 10) seem to suffer from an unfortunate translation from another language.
6. The authors should consider other potential limitations of their study: it was carried out in only one centre, with a limited number of participants, a specific decision-making environment and microbial ecology. 7. Figure 1 requires modification as it is difficult to distinguish between the guideline adherence and antibiotic free days symbols. 2. There needs to be more explanation about how covariates were chosen for the logistic regression models 3. The limitations section should be expanded. The fact that this is not a randomized controlled trial should be listed as a limitation. In addition, the method for determining adherence could have introduced biased since it is not obvious that there was any blinding.
REVIEWER
Nachtigall and colleagues report on the results of an intervention using a computerized decision support system to improve guideline adherence for treating infections in their surgical ICU.
The major strength of this study is that it spans a 5-year time period enabling the long-term consequences of this intervention to be examined.
One significant limitation is study design. The authors comment that they could not have performed a randomized trial because it would be unethical not to follow guidelines for the control patients. Not following guidelines would clearly be unethical, however they could have compared paper guidelines (as provided in the pre-period) to CDSS by randomly assigning the interventions to units or physicians. It"s understandable why they used a before/after design (it may be that their intention was to implement a quality improvement initiative throughout the ICU in a timely manner, and the study was a secondary goal) but in terms of actually studying the effect of this intervention, a randomized trial would have been better. The authors should state this limitation.
Major comments: 1. The authors should explain why and how they chose their 4 time periods. Over the course of 5 years, they only present data from 12 non-consecutive, non-evenly spaced months. In addition, there is >2 year gap in the middle of the study that is unexplained. 2. I would have liked to understand more about the CDSS. Was it part of the electronic health record, or a separate application? How often did physicians use the CDSS? Was it specifically part of their workflow or did they just have access to it if they needed it? How were the algorithms presented? A screenshot may be helpful to the reader if available. One outcome was antibiotic-free days. How do the authors hypothesize that the CDSS helped with this? Did the CDSS specifically encourage stopping antibiotics when no longer necessary, or was it just better adherence to appropriate lengths of therapy? 3. Were there any precautions taken to reduce bias when evaluating for guideline adherence? If the evaluators were aware that they were looking at data from control or intervention times, this might bias their findings of adherence, which could potentially be subjective. 4. In the multivariable models, the authors do not explain how they chose the covariates. Were they significant in univariate analysis? Or thought to be important confounders? Especially in table 4, most of the covariates are not significant in the regression model and it is unclear why they were included. Also, it would be interesting to look at a logistic regression model with antibiotic free days as a variable to see whether its relationship with time period remained after adjusted for possible confounders. I would also be interested to know if there were other ways to compare the outcomes during the different time periods. Would time series analysis be of any use? It may be useful to have a formal statistical review. 5. If all patients, regardless of infection were included in analysis, it would be helpful to list in table 1 the percentage of overall infection in each time period. Maybe antibiotic free days increased because there were fewer infections. In fact, wound and soft tissue infections significantly decreased over time, and given this is a surgical ICU I would think that would account for a majority of the antibiotic use.
Minor comments: 1. In the introduction, a reference should be cited for the statement beginning "However, although intensive efforts have demonstrated…" on line 18, page 6. The next sentence starting on line 22 should be clarified. What are the "difficulties in prompt prescribing"? 2. On page 10 line 36, the categories of discrepancy are not entirely clear. Maybe a table with examples might be useful. Do the researchers have data on which of these discrepancies was the most common over the time periods? 3. Is it possible that the finding that mortality is lower for patients with good guideline adaherence is just reflective of the fact that for sicker patients, physicians might stray from guidelines when initial treatments are ineffective? For example they might extend an antibiotic course or cover more broadly that is usually necessary?
VERSION 1 -AUTHOR RESPONSE
First, we would like to thank the reviewers for their well-considered and attentive comments. In the following we will answer the questions that have been raised point by point; we have also highlighted the changes in the paper with blue font colour accordingly. We are very grateful for the advices that were suggested as they significantly improved the manuscript.
One of the main issues raised is the description of the system. Therefore, we have expanded the methods section. In addition we would like to offer the link to access the English version of the current CDSS which is free of charge and requires only a registration in the online system (http://www.dgaiabx.de/en/). Additionally we included screenshots to illustrate how the CDSS works.
Another important point was the question of trial design as non-randomized trials can not infer on causality. For our institution there was no option to conduct a randomized-controlled design and to allocate patients to study groups as there would result a sustaining carry over effect from one patient to another treated in the same ICU but allocated to different groups. This effect would also occur in the cluster RCT design as there is significant staff rotation between participating ICUs over time. The issue of study design in this field has also been discussed in prior publications and when the study was initiated in 2005 (e.g. Sintchenko et al. in J Am Med Inform Assoc. 2005 ) and this pragmatic observational before-after design was the most feasible for our institution.
Please find uploaded our detailed answers to the review in a file uploaded in the section "Review history" including figures and tables. Additionally, we attached the document to an eMail that was send to the editorial office.
Once again, we would like to thank the Editorial team and all Reviewers for their comments on the manuscript. 
VERSION 2 -REVIEW REVIEWER

GENERAL COMMENTS
This study describes the implementation of a CDSS at one institution and reports on the long term effect of this tool in terms of antibiotic free days and guideline adherence.
The authors did an excellent job responding to the reviewers' criticisms. With the addition of detail regarding the CDSS, identification of study limitations, and a clearer explanation of study design, the new version of the manuscript is significantly improved compared to the original. Although there are still limitations to this study, I think it is a useful addition to the literature as a description of one institution's experience with the long term use of a CDSS for antibiotic prescribing.
Of note, there are several typographical errors that should be corrected in the new version.
